These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
283 related items for PubMed ID: 16549536
1. Erythrocyte metabolism and antioxidant status of patients with Wilson disease with hemolytic anemia. Attri S, Sharma N, Jahagirdar S, Thapa BR, Prasad R. Pediatr Res; 2006 Apr; 59(4 Pt 1):593-7. PubMed ID: 16549536 [Abstract] [Full Text] [Related]
2. Acute hemolytic anemia as an initial presentation of Wilson disease in children. El Raziky MS, Ali A, El Shahawy A, Hamdy MM. J Pediatr Hematol Oncol; 2014 Apr; 36(3):173-8. PubMed ID: 24577547 [Abstract] [Full Text] [Related]
3. Plasma copper and antioxidant status in Wilson's disease. Ogihara H, Ogihara T, Miki M, Yasuda H, Mino M. Pediatr Res; 1995 Feb; 37(2):219-26. PubMed ID: 7731761 [Abstract] [Full Text] [Related]
7. Abnormalities of chemical tests for copper metabolism in chronic active liver disease: differentiation from Wilson's disease. LaRusso NF, Summerskill WH, McCall JT. Gastroenterology; 1976 May; 70(5 PT.1):653-5. PubMed ID: 1261757 [Abstract] [Full Text] [Related]
11. Effect of pentylenetetrazol-induced epileptic seizure on the antioxidant enzyme activities, glutathione and lipid peroxidation levels in rat erythrocytes and liver tissues. Akbas SH, Yegin A, Ozben T. Clin Biochem; 2005 Nov; 38(11):1009-14. PubMed ID: 16122723 [Abstract] [Full Text] [Related]
12. Treatment with D-penicillamine or zinc sulphate affects copper metabolism and improves but not normalizes antioxidant capacity parameters in Wilson disease. Gromadzka G, Karpińska A, Przybyłkowski A, Litwin T, Wierzchowska-Ciok A, Dzieżyc K, Chabik G, Członkowska A. Biometals; 2014 Feb; 27(1):207-15. PubMed ID: 24368744 [Abstract] [Full Text] [Related]
13. A clinical study of Wilson's disease: The experience of a single Egyptian Paediatric Hepatology Unit. El-Karaksy H, Fahmy M, El-Raziky MS, El-Hawary M, El-Sayed R, El-Koofy N, El-Mougy F, El-Hennawy A, El-Shabrawi M. Arab J Gastroenterol; 2011 Sep; 12(3):125-30. PubMed ID: 22055589 [Abstract] [Full Text] [Related]
14. Childhood Wilson Disease: Bangladesh Perspective. Rukunuzzaman M, Karim AB, Nurullah M, Sultana F, Mazumder MW, Rahman MA, Billah SB, Begum F, Oliullah M. Mymensingh Med J; 2017 Apr; 26(2):406-413. PubMed ID: 28588179 [Abstract] [Full Text] [Related]
15. A study of oxidative stress, cytokines and glutamate in Wilson disease and their asymptomatic siblings. Kalita J, Kumar V, Misra UK, Ranjan A, Khan H, Konwar R. J Neuroimmunol; 2014 Sep 15; 274(1-2):141-8. PubMed ID: 25002079 [Abstract] [Full Text] [Related]
16. Relevance of non-ceruloplasmin copper to oxidative stress in patients with hepatocellular carcinoma. Geetha A, Saranya P, Annie Jeyachristy S, Surendran R, Sundaram A. Biol Trace Elem Res; 2009 Sep 15; 130(3):229-40. PubMed ID: 19229483 [Abstract] [Full Text] [Related]
18. Value of an enzymatic assay for the determination of serum ceruloplasmin. Macintyre G, Gutfreund KS, Martin WR, Camicioli R, Cox DW. J Lab Clin Med; 2004 Dec 15; 144(6):294-301. PubMed ID: 15614251 [Abstract] [Full Text] [Related]
20. Diagnosis and characterization of presymptomatic patients with Wilson's disease and the use of molecular genetics to aid in the diagnosis. Yuzbasiyan-Gurkan V, Johnson V, Brewer GJ. J Lab Clin Med; 1991 Nov 15; 118(5):458-65. PubMed ID: 1940586 [Abstract] [Full Text] [Related] Page: [Next] [New Search]